| Nov 19 |
Reasons to Retain BSX Stock in Your Portfolio for Now
|
| Nov 19 |
BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
|
| Nov 19 |
Boston Scientific Stock Set to Gain From Completion of Axonics Deal
|
| Nov 18 |
Boston Sci stock climbs 5% on positive Watchman FLX data
|
| Nov 18 |
Inside a $400 billion bet on the brain-computer interface revolution
|
| Nov 18 |
Here's Why We Think Boston Scientific (NYSE:BSX) Might Deserve Your Attention Today
|
| Nov 18 |
Boston Scientific’s Watchman could be new option for patients post ablation: study
|
| Nov 18 |
The PFA race is heating up. Here’s where the market stands after J&J’s approval.
|
| Nov 18 |
Boston Scientific reports outcomes from trial of LAAC device
|
| Nov 16 |
Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
|
